Global Immuno-Oncology Market Growth (Status and Outlook) 2025-2031

The global Immuno-Oncology market size is predicted to grow from US$ 56260 million in 2025 to US$ 133260 million in 2031; it is expected to grow at a CAGR of 15.5% from 2025 to 2031.

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body"s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The industry"s leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.

LPI (LP Information)' newest research report, the “Immuno-Oncology Industry Forecast” looks at past sales and reviews total world Immuno-Oncology sales in 2024, providing a comprehensive analysis by region and market sector of projected Immuno-Oncology sales for 2025 through 2031. With Immuno-Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-Oncology industry.

This Insight Report provides a comprehensive analysis of the global Immuno-Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno-Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-Oncology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-Oncology.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others

Segmentation by Application:
Hospitals
Drugstores
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA

Please note: The report will take approximately 2 business days to prepare and deliver.